1-6 of 6
Massimo Massi-Benedetti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment of Type 2 Diabetes With Combined Therapy : What are the pros and cons?

Massimo Massi-Benedetti, Marco Orsini-Federici
Journal: Diabetes Care
Diabetes Care 2008;31(Supplement_2):S131–S135
https://doi.org/10.2337/dc08-s233
Published: 01 February 2008
View article titled, Treatment of Type 2 Diabetes With Combined Therapy : <subtitle>What are the pros and cons?</subtitle>
Open the PDF for Treatment of Type 2 Diabetes With Combined Therapy : <subtitle>What are the pros and cons?</subtitle> in another window
Journal Articles

Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease: Data from the PROactive Study (PROactive 08)

Erland Erdmann, MD, FESC, FACC, Bernard Charbonnel, MD, Robert G. Wilcox, MD, Allan M. Skene, PHD, Massimo Massi-Benedetti, MD, John Yates, MD, Meng Tan, MD, Robert Spanheimer, MD, Eberhard Standl, MD, John A. Dormandy, FRCS, DSC, On behalf of the PROactive investigators
Journal: Diabetes Care
Diabetes Care 2007;30(11):2773–2778
https://doi.org/10.2337/dc07-0717
Published: 01 November 2007
View article titled, Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease: <subtitle>Data from the PROactive Study (PROactive 08)</subtitle>
Open the PDF for Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease: <subtitle>Data from the PROactive Study (PROactive 08)</subtitle> in another window
Includes: Supplementary data
Journal Articles

Reduced Hypoglycemia Risk With Insulin Glargine: A meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes

Julio Rosenstock, MD, George Dailey, MD, Massimo Massi-Benedetti, MD, Andreas Fritsche, MD, Zhengning Lin, PHD, Alan Salzman, MD
Journal: Diabetes Care
Diabetes Care 2005;28(4):950–955
https://doi.org/10.2337/diacare.28.4.950
Published: 01 April 2005
View article titled, Reduced Hypoglycemia Risk With Insulin Glargine: <subtitle>A meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes</subtitle>
Open the PDF for Reduced Hypoglycemia Risk With Insulin Glargine: <subtitle>A meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes</subtitle> in another window
Journal Articles

The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive): Can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5,238 patients

Bernard Charbonnel, MD, John Dormandy, FRCS(ED), FRCS(ENG), DSC, Erland Erdmann, MD, FESC, FACC, Massimo Massi-Benedetti, MD, Allan Skene, PHD, PROactive Study Group
Journal: Diabetes Care
Diabetes Care 2004;27(7):1647–1653
https://doi.org/10.2337/diacare.27.7.1647
Published: 01 July 2004
View article titled, The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive): <subtitle>Can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5,238 patients </subtitle>
Open the PDF for The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive): <subtitle>Can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5,238 patients </subtitle> in another window
Journal Articles

The Relationship Between Physicians’ Self-Reported Target Fasting Blood Glucose Levels and Metabolic Control in Type 2 Diabetes: The QuED Study Group—Quality of care and outcomes in type 2 diabetes

The QuED Study Group Writing Committee Coordinating Center:, Maurizio Belfiglio, MD, Giorgia De Berardis, MSC (chem), Monica Franciosi, MSC (biol), Donatella Cavaliere, MD, Barbara Di Nardo, HSDIP, Sheldon Greenfield, MD, Sherrie H. Kaplan, PHD, MPH, Fabio Pellegrini, MS, Michele Sacco, MD, Gianni Tognoni, MD, Miriam Valentini, MD, Antonio Nicolucci, MD, Scientific Committee:, Vittorio Caimi, MD, Fabio Capani, MD, Andrea Corsi, MD, Roberto Della Vedova, MD, Massimo Massi Benedetti, MD, Antonio Nicolucci, MD, Claudio Taboga, MD, Massimo Tombesi, MD, Giacomo Vespasiani, MD
Journal: Diabetes Care
Diabetes Care 2001;24(3):423–429
https://doi.org/10.2337/diacare.24.3.423
Published: 01 March 2001
View article titled, The Relationship Between Physicians’ Self-Reported Target Fasting Blood Glucose Levels and Metabolic Control in Type 2 Diabetes: <subtitle>The QuED Study Group—Quality of care and outcomes in type 2 diabetes</subtitle>
Open the PDF for The Relationship Between Physicians’ Self-Reported Target Fasting Blood Glucose Levels and Metabolic Control in Type 2 Diabetes: <subtitle>The QuED Study Group—Quality of care and outcomes in type 2 diabetes</subtitle> in another window
Journal Articles

A Comprehensive Assessment of the Avoidability of Long-Term Complications of Diabetes. A case-control study. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration

Antonio Nicolucci, MD, Donatella Cavaliere, MD, Nicola Scorpiglione, MD, Fabrizio Carinci, MS, Fabio Capani, MD, Gianni Tognoni, MD, Massimo Massi Benedetti, MD
Journal: Diabetes Care
Diabetes Care 1996;19(9):927–933
https://doi.org/10.2337/diacare.19.9.927
Published: 01 September 1996
View article titled, A Comprehensive Assessment of the Avoidability of Long-Term Complications of Diabetes. A case-control study. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration
Open the PDF for A Comprehensive Assessment of the Avoidability of Long-Term Complications of Diabetes. A case-control study. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration in another window